# Diabetic Ketoacidosis Presenting With New-Onset Generalized Tonic–Clonic Seizures and Status Epilepticus in a Previously Undiagnosed Diabetic Patient: A Case Report

**Authors:** Fatima Aziouaz, Dalia Kaadan, Wiam Ftouh, Yousra Dakkon, Mariem Benkacem

PMC · DOI: 10.7759/cureus.100794 · Cureus · 2026-01-05

## TL;DR

A man with undiagnosed diabetes experienced seizures due to severe diabetic ketoacidosis, highlighting the need for early metabolic evaluation in such cases.

## Contribution

This case report highlights the rare presentation of diabetic ketoacidosis as the initial manifestation of latent autoimmune diabetes in adults.

## Key findings

- Severe hyperglycemia, ketosis, and metabolic acidosis were confirmed in a patient with no known diabetes history.
- Neuroimaging and EEG ruled out other neurological causes, supporting ketoacidosis-induced seizures.
- Treatment with fluids, insulin, and phenobarbital led to clinical and biochemical improvement.

## Abstract

We present the case of a 47-year-old Moroccan male with no known history of diabetes who presented with new-onset status epilepticus. His family reported a one-year history of increasing lethargy, polyuria, polydipsia, significant weight loss, and polyphagia. Initial laboratory investigations revealed severe hyperglycemia (547 mg/dL), marked ketosis, and profound metabolic acidosis (bicarbonate level of 9 mmol/L), confirming the diagnosis of severe diabetic ketoacidosis. Further investigations, including an elevated HbA1c level (15.2%), positive anti-glutamic acid decarboxylase (GAD) antibodies (280 IU/mL), and a low fasting C-peptide level (0.06 ng/mL), supported the diagnosis of new-onset latent autoimmune diabetes in adults. Neuroimaging and electroencephalography ruled out other neurological etiologies, supporting diabetic ketoacidosis-induced status epilepticus as the most likely cause. Status epilepticus as the initial manifestation of diabetic ketoacidosis secondary to latent autoimmune diabetes in adults is rare and clinically challenging. Treatment consisted of intravenous fluids, regular insulin, and phenobarbital for seizure control, leading to progressive clinical and biochemical improvement. This case highlights the importance of early metabolic evaluation in adults presenting with new-onset seizures, even in the absence of previously known diabetes, to allow timely diagnosis and prevent severe neurological complications.

## Linked entities

- **Chemicals:** insulin (PubChem CID 70678557), phenobarbital (PubChem CID 4763)
- **Diseases:** diabetic ketoacidosis (MONDO:0012819), latent autoimmune diabetes in adults (MONDO:0850306)

## Full-text entities

- **Genes:** GAD1 (glutamate decarboxylase 1) [NCBI Gene 2571] {aka CPSQ1, DEE89, GAD, GAD-67, SCP}
- **Diseases:** Seizures (MESH:D012640), metabolic acidosis (MESH:D000138), ketosis (MESH:D007662), lethargy (MESH:D053609), polydipsia (MESH:D059606), polyphagia (MESH:D006963), hyperglycemia (MESH:D006943), Tonic (MESH:D004829), Status Epilepticus (MESH:D013226), polyuria (MESH:D011141), neurological complications (MESH:D002493), autoimmune diabetes (MESH:D003922), Diabetic (MESH:D003920), Diabetic Ketoacidosis (MESH:D016883), weight loss (MESH:D015431)
- **Chemicals:** bicarbonate (MESH:D001639), phenobarbital (MESH:D010634), C-peptide (MESH:D002096)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12869099/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12869099/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12869099/full.md

---
Source: https://tomesphere.com/paper/PMC12869099